82
H. Möhrle und M. Jeandree • Dehydrierung 4-substituierter Piperidine
C14H 17NO (215.3)
3.3-Dimethyl-l,2,3,4,4a,5-hexahydropyrido[l,2-a]-
chinolin-6-on (23)
Ber. C 78.10. H 7.96, N6.51%,
Gef. C 77.89, H 8.08, N6.51%.
Hg(II)-EDTA-Dehydrierung [5]: a) 1.00 g (4.33
mmol) 17; 40 ml Wasser; 1 h. Hg-Abscheidung:
3-Methyl-l,2,3,4-tetrahydropyrido[l,2-aJchinolin-
6-on (2 1 )
0.40 g (23% bez. auf 4 Oxid.-Äquiv.). b) 1.00 g
(4.33 mmol) 17; 40 ml Wasser; 3 h. Hg-Abschei-
dung: 1.22 g (70% bez. auf 4 Oxid.-Äquiv.). Die
resultierenden Gemische wurden säulenchromato-
graphisch mit einer Flash-Säule getrennt; Gradien-
Hg(II)-EDTA-Dehydrierung [5] vgl. Darstel-
lung von 20. Ausb. 40 mg (4%). Weiße Kristalle
aus Methylenchlorid/Ether. Schmp. 180 °C. - IR
(KBr): 3100; 3060; 2960; 2920; 2860; 1620; 1590; tenelution: FM III, FM II, FM V, FM I. Dabei wur-
den erhalten: a) 780 mg 17, 70 mg 23, 20 mg 24,
60 mg 25. b) 330 mg 17, 120 mg 23, 30 mg 24, 300
77 (75); 57 (82); 55 (76); 43 (94); 41 (100). - !H- mg 25. Rr Werte in FM II: 17: 0.65; 23: 0.46; 24:
1565; 1540; 1490 c m '1. - MS (140 °C): m/z (%) =
213 (47; M+); 185 (27); 143 (43); 115 (20); 105 (14);
0.04; 25: 0.21.
NMR (CDC13): (3(ppm) = 8.46 (dd, 1H, 7-H, V =
8.1, 4J = 1.1); 7.68-7.26 (m, 3H, 8-10-H); 6.11 (s,
1 H, 5-H); 4.25 (ddd, 1H, 1-Heq, V = 10, 3Jaxeq =
6.1, Veqeq = 3.5); 3.95 (td, 1H, 1-Hax, V = 10,
Vax, x= 10, V eq.ax = 5.2); 2.97 (ddd, 1 H, 4-Heq, V =
15.8,V ax,eq - 5, V 2_Heq.eq = 2.5); 2.80-1.56 (m, 4H,
2-H2, 3-H, 4-Hax); 1.14 (d, 3H, 3-CH3, V = 5.9).
23: Ausb. a) 70 mg (7%); b) 120 mg (12%). Gelb
fluoreszierendes Pulver, das analysenrein anfiel.
Schmp. 73 °C. - IR (KBr): 3060; 2960; 2910; 2840;
1660; 1600; 1560; 1485 c irr1. - MS (40 °C): m/z
(%) = 230 (19); 229 (93; M+); 228 (70); 214 (41);
201 (15); 196 (17); 186 (19); 172 (100); 158 (23);
146 (81); 132 (32); 130 (37); 117 (36); 77 (64); 41
(73). - 'H-NMR (CDC13): (3(ppm) = 7.93 (dd, 1H.
7-H. 3/ 8 7 = 7.9, % 7 = 1.8); 7.41 (ddd, 1H, 9-H,
3/ 109= 8 .6 , -V8 9 = 7, 4J19 = 1.8); 6.93 (d, 1H, 10-H,
3Jgio = 8 .6 ); 6.79 (ddd, 1H, 8 -H, V7 8 = 7.9,3Jg8 = 7,
4/ 10.8 = 0.7); 3.74 (ddd, 1H, 1-Heq, 2J = 12.6,
-Vax,eq = 4.9, 3Jeq.eq = 2.4); 3.45 (dddd, 1H, 4a-Hax,
X-Teil von ABX, Vax = 12.2, V4.Hax,4a-Hax = 10,
C14H 15NO (213.3)
Ber. C 78.84, H 7.09, N 6.57%,
Gef. C 78.57, H7.10, N6.50%.
1-(2-Acetylphenyl)-4-methylpiperidin-2-on (22)
Hg(II)-EDTA-Dehydrierung [5] vgl. Darstel-
lung von 20. Ausb. 430 mg (40%). Weiße Kristalle
aus Diisopropylether. Schmp. 37 °C. - IR (KBr):
3060; 2940; 2860; 1675; 1635; 1590; 1565; 1470
cm^1. - MS (50 °C): m/z (%) = 231 (2; M+); 216
V4-Heq.4a-Hax =
1-Hax, 2J = 12.6, 37ax,ax - 12.9, 3/ eq,ax = 3.8); 2.60
( d d , 1H, 5-Hb, 2Jab = 16.4, 3JXB = 3.9); 2.50 ( d d ,
^BX = 3.9); 2.84 (,td\ 1H,
(2); 188 (100); 174 (4); 161 (14); 146 (29); 133 (38); 1H, 5-Ha , 27 Ba = 16.4, VXA = 12.2); 1.64 ( , t d \ 1H,
77 (32); 43 (57). - 'H-NMR (Pyridin-d5): ö 2-Hax, 2J= 13.1, 3/ ax.ax = 12.9, Veq,ax = 4.9); 1.57-
1.51 (m, 1H, 2-Heq); 1.48-1.41 (m, 2H, 4-H2); 1.00
(s, 3H, 3-CH3 [*eq]); 0.99 (s, 3H, 3-CH3 [*ax]). Die
Zuordnung erfolgte aus den 'H /H - und 'H ,I3C-
Korrelationen, für * aus den 13C-NMR-Daten dar-
aus. - 13C-NMR (CDC13; DEPT): d (ppm) =
193.68 (C-6 ); 152.72 (C-lOa); 135.30 (C-9); 127.85
(C-7); 120.94 (C-6 a); 117.76 (C-8 ); 113.72 (C-10);
53.37 (C-4a); 45.57 (C-5); 45.35 (C-4); 43.19 (C-l);
37.43 (C-2); 32.19 (3-CH3 [eq]); 28.43 (C-3); 22.86
(3-CH3 [ax]). - UV (MeOH): Amax = 375 nm (lg
e = 3.60), 263 nm (lg £ = 4.03), 237 nm (lg £ =
(ppm) = 7.70 (dd, 1 H, 3'-H, V = 8 , 4J = 1.5); 7.48
(ddd, 1 H, 5'-H, V = 8 , V = 7.5, V = 1.5); 7.31 (,d‘,
IH, 4'-H, ,J‘ = 7.5) überlagert 7.29 (,dd‘, 1H, 6 '-H,
V = 8 , 4J = 1.5); 3.68 (td, 1H, 6 -Hax, 2J = 11.3,
Vax,ax = 11.3, Veq.ax = 5); 3.55 (ddd, 1H, 6 -Heq, 2J =
II.3, Vax.eq = 5.5, Veq,eq = 3.5); 2.61-2.52 (m, 1H.
3-Heq); 2.57 (s, 3H, COCH3); 2.05 (dd, 1H, 3-Hax,
2J = 17, Vaxax - 10,7); 1.99-1.85 (m, 1H, 4-Hax);
1.71 (dddd, 1H, 5-Heq, 2J = 11, V 4.Hax,eq = 6.5,
^ 6-H ax,eq
=
5 , V 6. H eq.eq ~_3-5); 1.50 (tdd, 1H, 5-Hax,
J
~
H > ^4-Hax.ax — 1 3 , '«/ft-Hax.ax
~
H > -^ö-Heq.ax —
5.5); 0.85 (d, 3H, 4-CH3(eq), V = 6.5). - 13C-NMR 4.03).
(Pyridin-ds): <5 (ppm) = 200.16 (COCH3); 169.60
C,,H 19NO (229.3)
(C-2); 141.52 (C-l'); 138.55 (C-2'); 132.37 (C-5');
128.53 (C-3'); 128.25 (C-6 '); 127.23 (C-4'); 51.01
(C-6 ); 41.29 (C-3); 31.14 (C-5); 28.92 (COCH3);
28.06 (C-4); 20.99 (4-CH3). Signalzuordnung auf-
grund von 'H ,13C-Korrelationen.
Ber. C 78.56, H 8.35, N 6 ,ll% ,
Gef. C 78.27, H 8.17, N5.97%.
3.3-Dimethyl-l,2,3,4-tetrahydropyrido[l,2-a]chino-
lin-6-on (24)
C14H 17N 0 2 (231.3)
Hg(II)-EDTA-Dehydrierung [5] vgl. Darstel-
lung von 23. Ausb. a) 20 mg (2%); b) 30 mg (3%).
Ber. C 72.70, H 7.41, N 6.06%,
Gef. C 72.70, H7.61, N 6.05%.
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 8/3/15 3:20 PM